Latham & Watkins has advised Grünenthal GmbH (Grünenthal), a leading pharmaceutical company in the area of pain management, on the issuance of €300 million bond aggregate principal amount of 6.75% senior secured notes due 2030.
The Latham team was led by Munich partner Rüdiger Malaun and Frankfurt partner Alexander Lentz, with Frankfurt counsel Gregory Walker and associate Laura Neumann. The Latham team worked closely with Grünenthal’s in-house team led by General Counsel Sebastian Köhler.
Where the legal industry reads first.
Enjoyed this article? Get the biggest legal industry updates, deals, appointments, insights and expert interviews in your inbox, free.
No spam. Unsubscribe anytime.From Legal Desire
Is your firm the one being cited, or the one being skipped?
We ran the test. On several everyday legal questions, software companies are answering and law firms are not. We help firms fix that, and we build the technology behind the practice.
Lawyers and firms: get featured on Legal Desire
Share your deals, lateral moves, firm news and insights with 1M+ monthly readers: founders, law firm partners, general counsel and practising lawyers across the US, UK, EU and GCC.
Get featuredSubmit a press releaseThe advising firms, the named deal team, the value and the parties, with every other announced deal by the same firms and lawyers. Open the deal record
